Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLC
Clinical trial NCT04144608 · COMPLETED
Trial details
- NCT number
- NCT04144608
- Sponsor
- Yongchang Zhang
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-16
- Primary completion
- 2022-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.